Global Metabolic Disorder Therapeutics Market Size, Industry Trends, Share and Forecast 2020-2026

 The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment. For instance, in May 2020, POXEL SA, a biopharmaceutical company focused to develop innovative treatments for metabolic disorders, such as non-alcoholic steatohepatitis (NASH) and type 2 diabetes declared new preclinical results for PXL770. It is a direct adenosine monophosphate-activated protein kinase(AMPK) activator, was assessed in a rodent NASH model along with other major agents in development, such as a thyroid receptor  agonist (MGL-3196), an FXR agonist (obeticholic acid), and a GLP-1 receptor agonist (semaglutide).  

A full Report of Global Metabolic Disorder Therapeutics Market Available at  https://www.omrglobal.com/industry-reports/metabolic-disorder-therapeutics-market 

The outcomes feature PXL770 as a potential new NASH therapy that may develop complementary advantages while combined with other agents with different action mechanisms. Further, in September 2020, Kaleido Biosciences, Inc. declared that it has evaluated Microbiome Metabolic Therapy (MMT) candidate KB295 in the first patient suffering from mild-to-moderate ulcerative colitis. Such kinds of clinical studies are offering an opportunity for new launches of innovative therapies for metabolic disorders, which in turn, will further accelerate the market growth. 

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/metabolic-disorder-therapeutics-market 

Scope of the Global Metabolic Disorder Therapeutics Market 

Market Coverage 

  • Market number available for 2019-2026
  • Base year- 2019
  • Forecast period- 2020-2026
  • Segment Covered- By Therapy and Disease
  • Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
  • Competitive Landscape- AbbVie, Inc., Novo Nordisk A/S, Sanofi SA, Boehringer Ingelheim GmbH, and AstraZeneca plc 

Recent Strategic Initiatives in the Global Metabolic Disorder Therapeutics Market 

  • In March 2020, AstraZeneca plc declared the collaboration with Silence Therapeutics for discovery, development, and commercialization of small interfering RNA (siRNA) therapeutics to treat CVD, respiratory, renal, and metabolic disorders. This multi-target partnership will use the established small interfering RNA (siRNA) platform of Silence to detect and progress liver-based targets and develop new delivery methods to target other tissues including the heart, kidney, and lung. 
  • In March 2020, Eli Lilly and Co. declared the global licensing and research partnership with Sitryx, a biopharmaceutical company engaged in the development of therapeutics in immuno-inflammation and immuno-oncology. Under the partnership, the companies will study up to four new preclinical targets that are identified by Sitryx that could result in potential new medicines for autoimmune diseases. Lilly will make a $10 million equity investment in Sitryx and Sitryx will get an upfront payment of $50 million. 

Key questions addressed by the report 

  • What is the market growth rate?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market?
  • How COVID-19 impacted the market?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity? 

Global Metabolic Disorder Therapeutics Market-Segmentation 

By Therapy 

  • Drug Therapy
  • Gene Therapy
  • Cellular Transplantation
  • Enzyme Replacement Therapy
  • Others 

By Disease 

  • Obesity
  • Diabetes
  • Lysosomal Storage Disease
  • Hypercholesterolemia
  • Others 

Global Metabolic Disorder Therapeutics Market– Segment by Region  

North America 

  • United States
  • Canada 

Europe 

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe  

Asia-Pacific 

  • China
  • India
  • Japan
  • Rest of Asia-Pacific  

Rest of the World 

  • Latin America
  • The Middle East and Africa 

Company Profiles 

  • AbbVie, Inc.
  • Actelion Pharmaceuticals, Ltd.
  • Agios Pharmaceuticals, Inc.
  • Alexion Pharmaceuticals, Inc.
  • Amgen, Inc.
  • AstraZeneca plc
  • Biocon, Ltd.
  • BioMarin Pharmaceutical, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co.
  • Cipla, Inc.
  • CymaBay Therapeutics, Inc.
  • Dracen Pharmaceuticals, Inc.
  • Eli Lilly and Co.
  • Intra-Cellular Therapies, Inc.
  • Merck KGaA
  • Novo Nordisk A/S
  • Orchard Therapeutics plc
  • Pfizer, Inc.
  • Sanofi S.A.
  • Shire Pharmaceuticals Group plc
  • Sigilon Therapeutics, Inc.
  • Silence Therapeutics 

 For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/metabolic-disorder-therapeutics-market 

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. 

For More Information, Visit Orion Market Research 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com  

Contact no: +91 780-304-0404

Comments

Post a Comment

Popular posts from this blog

Antidiarrheals Market to see Huge Growth by 2028

Antidiarrheals Market research report greatly helps to understand comprehensive profile of ideal customers. It also ascertains the market size for your business. Understanding of customers has great significance in the business expansion as it allows making right investment in the product development and launch. Making more informed decision is easy with this market research report. Identifying right business opportunities and maintaining customer-centric approach is easy with this market research report. It also enables to stay on the top of market trends and helps to reduce business risks. Antidiarrheals Market study report provides best solutions to deal with upcoming challenges. Market research serves as a valuable tool to stay up on current trends and know forthcoming competitive scenario for the estimation period 2022-2028. Get Sample Copy of this Report at   https://orionmarketreports.com/request-sample/?id=217314 Antidiarrheals Market study report serves as one of the cruci...
Read more

Nano Colloidal Silver Market Value Projected to Expand by 2028

Nano Colloidal Silver Market research report greatly helps to understand comprehensive profile of ideal customers. It also ascertains the market size for your business. Understanding of customers has great significance in the business expansion as it allows making right investment in the product development and launch. Making more informed decision is easy with this market research report. Identifying right business opportunities and maintaining customer-centric approach is easy with this market research report. It also enables to stay on the top of market trends and helps to reduce business risks. Nano Colloidal Silver Market study report provides best solutions to deal with upcoming challenges. Market research serves as a valuable tool to stay up on current trends and know forthcoming competitive scenario for the estimation period 2022-2028. Get Sample Copy of this Report at   https://orionmarketreports.com/request-sample/?id=217310 Nano Colloidal Silver Market study report serve...
Read more

Well Intervention Market Size, Share, Future Prospects and Forecast 2019-2025

  Well Intervention Market  size in 2017 was valued over USD 11 billion and is predicted to grow over 6% by 2025. The increase in mature oil and gas fields combined with the increasing demand for refined petroleum products due to rapid urbanization and industrialization of emerging economies will foster the oil well intervention market. The solid growth of aging oil fields, along with low exploration rates of new oil fields, will accelerate industrial growth. In addition, changes in the geological structure of oil wells will further accelerate industrial growth as demand for logging services increases. A full report of Well Intervention Market is available at: https://www.orionmarketreports.com/well-intervention-market/10625/ Increasing investments related to technological advancements to improve efficiency across the entire spectrum of exploration and production activities will fuel the growth of the global market. In addition, increased subsea production and the government's...
Read more